Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2004 4
2005 5
2006 12
2007 11
2008 14
2009 13
2010 4
2011 14
2012 10
2013 14
2014 10
2015 7
2016 10
2017 6
2018 12
2019 15
2020 8
2021 18
2022 19
2023 10
2024 9
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

192 results

Results by year

Filters applied: . Clear all
Page 1
Nivolumab Monotherapy and Nivolumab Plus Ipilimumab in Recurrent Small Cell Lung Cancer: Results From the CheckMate 032 Randomized Cohort.
Ready NE, Ott PA, Hellmann MD, Zugazagoitia J, Hann CL, de Braud F, Antonia SJ, Ascierto PA, Moreno V, Atmaca A, Salvagni S, Taylor M, Amin A, Camidge DR, Horn L, Calvo E, Li A, Lin WH, Callahan MK, Spigel DR. Ready NE, et al. Among authors: atmaca a. J Thorac Oncol. 2020 Mar;15(3):426-435. doi: 10.1016/j.jtho.2019.10.004. Epub 2019 Oct 17. J Thorac Oncol. 2020. PMID: 31629915 Free article. Clinical Trial.
Canakinumab in combination with docetaxel compared with docetaxel alone for the treatment of advanced non-small cell lung cancer following platinum-based doublet chemotherapy and immunotherapy (CANOPY-2): A multicenter, randomized, double-blind, phase 3 trial.
Paz-Ares L, Goto Y, Wan-Teck Lim D, Halmos B, Chul Cho B, Cobo M, Luis González Larriba J, Zhou C, Demedts I, Atmaca A, Baka S, Mookerjee B, Portella S, Zhu Z, Wu J, Demanse D, Dharan B, Reck M. Paz-Ares L, et al. Among authors: atmaca a. Lung Cancer. 2024 Mar;189:107451. doi: 10.1016/j.lungcan.2023.107451. Epub 2024 Jan 16. Lung Cancer. 2024. PMID: 38354535 Clinical Trial.
Evaluation and follow-up of patients diagnosed with hypophysitis: a cohort study.
Hacioglu A, Karaca Z, Uysal S, Ozkaya HM, Kadioglu P, Selcukbiricik OS, Gul N, Yarman S, Koksalan D, Selek A, Canturk Z, Cetinarslan B, Corapcioglu D, Sahin M, Sah Unal FT, Babayeva A, Akturk M, Ciftci S, Piskinpasa H, Dokmetas HS, Dokmetas M, Sahin O, Eraydın A, Fenkci S, Ozturk S, Akarsu E, Omma T, Erkan B, Burhan S, Pehlivan Koroglu E, Saygili F, Kilic Kan E, Atmaca A, Elbuken G, Alphan Uc Z, Gorar S, Hekimsoy Z, Pekkolay Z, Bostan H, Bayram F, Yorulmaz G, Sener SY, Turan K, Celik O, Dogruel H, Ertorer E, Turhan Iyidir O, Topaloglu O, Cansu GB, Unluhizarci K, Kelestimur F. Hacioglu A, et al. Among authors: atmaca a. Eur J Endocrinol. 2024 Aug 30;191(3):312-322. doi: 10.1093/ejendo/lvae101. Eur J Endocrinol. 2024. PMID: 39186535
Phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin: a study of the Arbeitsgemeinschaft Internistische Onkologie.
Al-Batran SE, Hartmann JT, Probst S, Schmalenberg H, Hollerbach S, Hofheinz R, Rethwisch V, Seipelt G, Homann N, Wilhelm G, Schuch G, Stoehlmacher J, Derigs HG, Hegewisch-Becker S, Grossmann J, Pauligk C, Atmaca A, Bokemeyer C, Knuth A, Jäger E; Arbeitsgemeinschaft Internistische Onkologie. Al-Batran SE, et al. Among authors: atmaca a. J Clin Oncol. 2008 Mar 20;26(9):1435-42. doi: 10.1200/JCO.2007.13.9378. J Clin Oncol. 2008. PMID: 18349393 Clinical Trial.
Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1/2 trial.
Antonia SJ, López-Martin JA, Bendell J, Ott PA, Taylor M, Eder JP, Jäger D, Pietanza MC, Le DT, de Braud F, Morse MA, Ascierto PA, Horn L, Amin A, Pillai RN, Evans J, Chau I, Bono P, Atmaca A, Sharma P, Harbison CT, Lin CS, Christensen O, Calvo E. Antonia SJ, et al. Among authors: atmaca a. Lancet Oncol. 2016 Jul;17(7):883-895. doi: 10.1016/S1470-2045(16)30098-5. Epub 2016 Jun 4. Lancet Oncol. 2016. PMID: 27269741 Free article. Clinical Trial.
The significance of finerenone as a novel therapeutic option in diabetic kidney disease: a scoping review with emphasis on cardiorenal outcomes of the finerenone phase 3 trials.
Arici M, Altun B, Araz M, Atmaca A, Demir T, Ecder T, Guz G, Gogas Yavuz D, Yildiz A, Yilmaz T. Arici M, et al. Among authors: atmaca a. Front Med (Lausanne). 2024 Jun 14;11:1384454. doi: 10.3389/fmed.2024.1384454. eCollection 2024. Front Med (Lausanne). 2024. PMID: 38947237 Free PMC article.
A soluble LAG-3 protein (eftilagimod alpha) and an anti-PD-L1 antibody (avelumab) tested in a phase I trial: a new combination in immuno-oncology.
Al-Batran SE, Mueller DW, Rafiyan MR, Kiselicki D, Atmaca A, Habibzada T, Mueller C, Brignone C, Triebel F, Loose M, Schaaf M, Sookthai D, Eickhoff R, Jaeger E, Goetze TO. Al-Batran SE, et al. Among authors: atmaca a. ESMO Open. 2023 Oct;8(5):101623. doi: 10.1016/j.esmoop.2023.101623. Epub 2023 Sep 22. ESMO Open. 2023. PMID: 37742484 Free PMC article. Clinical Trial.
Thiol/Disulfide Homeostasis in Patients With Erectile Dysfunction.
Micoogullari U, Karatas OF, Kisa E, Keskin MZ, Atmaca AF, Neselioglu S, Erel O, Ardicoglu A. Micoogullari U, et al. Among authors: atmaca af. J Sex Med. 2020 Oct;17(10):1934-1941. doi: 10.1016/j.jsxm.2020.07.011. Epub 2020 Aug 9. J Sex Med. 2020. PMID: 32788052 Clinical Trial.
192 results